Interested in specific Information?

Filter what you see here

Elderly patients

Quick poll

How first-generation novel regimens affect the risk of death in MM

How first-generation novel regimens affect the risk of death in MM

Closes Sep 19, 2018

General MM

Quick poll

Galinpepimut-S granted orphan drug designation by the EMA

Closes Sep 17, 2018

Relapsed/refractory patients,   General MM

Quick poll

Clarithromycin - the antibiotic of choice for osteonecrosis of the jaw in…

Closes Sep 14, 2018

General MM

Quick poll

APRIL regulates immunosuppression via TACI in the MM bone marrow

APRIL regulates immunosuppression via TACI in the MM bone marrow

Closes Sep 13, 2018

Relapsed/refractory patients

Quick poll

Evaluation of cell-free DNA as a biomarker in RRMM

Closes Sep 11, 2018

General MM,   Patients eligible for transplant

Quick poll

Comparison of three staging systems for newly diagnosed MM patients…

Closes Sep 7, 2018

General MM

Quick poll

DOT1L is a potential new target in MM

DOT1L is a potential new target in MM

Closes Sep 5, 2018

Patients non-eligible for transplant

Quick poll

The European Commission approves daratumumab as front-line treatment in…

Closes Sep 3, 2018

General MM

Quick poll

PVX-410 vaccine alone or with lenalidomide for patients with smoldering…

Closes Aug 29, 2018

Relapsed/refractory patients

Quick poll

Elotuzumab combo granted FDA priority review

Elotuzumab combo granted FDA priority review

Closes Aug 28, 2018

Patients eligible for transplant

Quick poll

Autologous transplantation using a simple method to store peripheral blood…

Closes Aug 28, 2018

General MM

Quick poll

Metabolomic profile of myeloma patients reveals potential new therapeutic…

Closes Aug 22, 2018

Patients eligible for transplant,   Patients non-eligible for transplant

Quick poll

Evaluation of ixazomib, with cyclophosphamide and dexamethasone, for newly…

Evaluation of ixazomib, with cyclophosphamide and dexamethasone, for newly diagnosed multiple myeloma

Closes Aug 21, 2018

General MM

Quick poll

TIGIT: a potential target for checkpoint inhibition in multiple myeloma

Closes Aug 20, 2018

General MM

Quick poll

Multiple myeloma diagnosis in primary care

Closes Aug 15, 2018
A global online educational platform sharing the latest research and emerging treatment information in multiple myeloma

Latest Medical Information

Latest Congress Coverage

English & German
English & German
General MM,Patients non-eligible for transplant,Patients eligible for transplant

Hermann Einsele | EHA 2018 | New concepts in consolidation for patients with NDMM

Jun 19, 2018
Patients eligible for transplant,Patients non-eligible for transplant

Charlotte Pawlyn | EHA 2018 | Results from Myeloma XI trial

Jun 18, 2018

Latest Biology

Relapsed/refractory patients

Evaluation of cell-free DNA as a biomarker in RRMM

Sep 11, 2018

Latest Drug Updates

Recently updated Licenses

Where we are next

European School of Haematology (ESH) 4th International Conference on Multiple Myeloma

October 5–7, 2018 | Mandelieu, FR

The MM Hub will be attending the European School of Hematology (ESH) 4th International Conference on Myeloma, to be held in Mandelieu, France, from 5-7 October 2018. The meeting will be chaired by Kenneth C. Anderson, Maria Victoria Mateos, and Philippe Moreau, and will take place in the Congress Mandelieu Expo Center. The meeting attracts world-class leaders who present the latest clinical data and debate important and contentious issues in MM. 
#mmsm

Event Website

Map Data
Map data ©2018 Google
Map DataMap data ©2018 Google
Map data ©2018 Google

Connect with us

Our sister hubs

Visit our other community physician education hubs in haematology and oncology